No insider purchase over the last 90 days. The latest, by 박재민, was filed 15 May 2026.
CellBion Co., Ltd.: what insiders have been doing
Every trade that managers of CellBion Co., Ltd. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. The last twelve months, up to 23 October 2026, brought 2 filings signed by 2 insiders.
Only purchases show up on the open market, 1 purchase in all worth €111k, filed by 1 insider. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 박재민 filed the largest purchase, €111k, on 15 May 2026, which represents 0.093% of the company's market value. The buyers include 1 senior executive.
With 2 filings in twelve months, the company is quieter than the median of 7 filings across the 2,650 companies we follow on the same exchange. Since 2024, the database holds 7 purchases and no sales by insiders of the company.
The most recent open-market purchase was published on 15 May 2026, 179 days ago.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -54.9%Entry ₩25,850 · Close 23 Oct 2026 ₩11,660
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 20,298 shares@ ₩9,360.000.093% mcap100.0% of flowShareKRXDART:20260514001504Canonical exit: 5 Aug 2026 (T+90)
- ●Executives0DART
- ShareKRXDART:20241111000087
- 452,946 sharesKRXDART:20241023000264Canonical exit: 14 Jan 2025 (T+90)
- 17,500 sharesShareKRXDART:20241022000151Canonical exit: 20 Jan 2025 (T+90)
- 80,149 sharesShareKRXDART:20241022000093Canonical exit: 20 Jan 2025 (T+90)
- ShareKRXDART:20241022000097Canonical exit: 14 Jan 2025 (T+90)
- 4,712,526 sharesKRXDART:20241022000129Canonical exit: 14 Jan 2025 (T+90)
- 3,879,423 sharesShareKRXDART:20241022000092Canonical exit: 20 Jan 2025 (T+90)
9 of 9 declarations
About CellBion Co., Ltd.
셀비온 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for the medical sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
